Indero is all in with dermatology and rheumatology research. Make an impact on patientsâ lives around the world by participating in cutting-edge clinical research, supported by Indero.
Indero is a dual-focus CRO for immune-mediated diseases that has been contributing to clinical research and development for over 25 years (formerly under the Innovaderm brand). Weâve supported over 500 clinical trials across over 30 indications, and can support early phase and late phase studies around the world.
We bring a unique clinical perspective to every study we run. From treating patients to collaborating with physicians, we provide the ideal level of CRO support all the way to the site level.
Partner investigators participate in cutting-edge research and actively contribute to the advancement of novel therapies that help improve patient care. Plus, Indero gives our partners access to the latest developments in dermatology and rheumatology so you can stay up to date.
Speed, Support & Payments
Indero helps accelerate site selection and start-up activities, and offers a fast, flexible contract and budget process. We also provide a quick turnaround time on payments.
Recruitment support
Indero establishes ongoing, tailored communication and support for activities such as advertising material, media placement, and personalized recruitment strategies.
Medical & scientific expertise
Indero understands your study needs. Our medical and clinical teams are well-versed in the science behind our studies. Their expertise is a significant advantage for the sites.
Dr. Mark Lee
Progressive Clinical Research, Texas, USA
âWe know that we can always rely on them to put their central campaign expertise and advertisement knowledge within the clinical research industry to good use.â
Join Our Global Network
Indero partners with investigators across the world to advance dermatology and rheumatology research where patients need it most. Tell us about your site setting, research experience and interest, and weâll be in touch.
We are excited to announce that Innovaderm is rebranding our CRO division as Indero (in-dAIR-oh). This rebranding reflects our ongoing commitment to innovation and our expansion into the field of rheumatology, a therapeutic area closely linked to dermatology. As a dual-focus CRO specializing in both dermatology and rheumatology, this strategic decision marks a significant milestone for our organization, and we are eager to embark on this new chapter with our valued partners and clients. Additionally, our Clinical Research Unit (CRU) will keep the name Innovaderm and will continue to conduct dermatology studies.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.